Intranasal Corticosteroids Market size was valued at USD 7.13 billion in 2024 and is likely to cross USD 13.61 billion by 2037, registering more than 5.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of intranasal corticosteroids is estimated at USD 7.44 billion.
The growth of the market can be attributed to the growing prevalence of sinusitis across the globe. Data published by the National Library of Medicine showed that in 2022, around 90% of people having a cold showed the symptoms of viral sinusitis.
Furthermore, the global intranasal corticosteroids market is expanding its size exponentially on the back of rising cases of cold and fever. Nasal corticosteroids, a member of the steroids family, are cortisone-like medicine and can be administered by two methods, sprayed and inhaled. Nasal corticosteroids are utilized by people to prevent irritation, discomfort, stuffy nose, and another sort of allergies. The expansion in the global intranasal corticosteroids market size is backed by the frequently occurring nasal problems such as sinus infection, airway blockage, congestion, and others. For instance, it is observed that around 0.6% of respiratory tract infections are caused by sinusitis and it can range from 20 to 45 episodes per 1000 individuals annually.
Growth Drivers
Growing Geriatric Population with Low Autoimmune System to Hike the Market Growth:- Based on the statistics provided by the World Bank, in 2020, the global geriatric population was stated to be 723,595,779.
Increasing Sector of Cold & Cough Remedies - As of 2022, the cold & cough remedies sector was valued at approximately USD 40 billion.
Higher Prevalence of Cold and Flu - As per the report provided by the National Library of Medicine (NLM) in 2019, nearly 0.3 million people died on account of influenza across the globe.
Significant Demand in Allergic Rhinitis Treatment - The industry for global allergic rhinitis treatment is anticipated to reach around USD 7 billion by the year 2024.
Escalating per Capita Healthcare Expenditure Across the Globe - World Health Organization published a report demonstrating healthcare expenditure per capita in 2019 to be USD 1,121.97.
Challenges
Possibility of Side Effects such as Crusting and Nosebleed
Significant Number of People with Rhinophobia
Presence of Alternative Methods to Treat Allergies
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.1% |
|
Base Year Market Size (2024) |
USD 7.13 billion |
|
Forecast Year Market Size (2037) |
USD 13.61 billion |
|
Regional Scope |
|
The global intranasal corticosteroids market is segmented and analyzed for demand and supply by administration into aerosol liquid, spray, and implants, out of which, the spray segment is anticipated to hold the notable share in the global intranasal corticosteroids market during the forecast period on account of the flexible administration and convenient affordability. It is directly applied or sprayed into the nasal passage to reduce inflammation in conditions such as cold and fever. According to American Lung Fever Association, around 200 types of viruses are responsible to cause colds and other minor infections. Additionally, an individual can get 2 to 4 colds per year. Furthermore, intranasal corticosteroids are highly available in spray form.
Our in-depth analysis of the global market includes the following segments:
|
By Drugs Type |
|
|
By Rhinitis Type |
|
|
By Adminstartion |
|
|
By Distribution Channel |
|
Regionally, the global intranasal corticosteroids market is studied into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Asia Pacific industry is predicted to account for largest revenue share by 2037, on account of higher prevalence of type 1 diabetes, rheumatoid arthritis, and other types of scleros. China and India are the countries with a skyrocketing prevalence of type 1 diabetes since half of the total diabetes patients in the Asia Pacific are living in these two countries. Based on the data provided by the International Diabetes Federation in 2021, it was stated that 90 million people have diabetes in South-East Asia while the figure is further expected to reach 152 million over the forecast period. Hence, the market is anticipated to grow at a significant pace over the forecast period in the Asia Pacific Region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?